CFTR inhibition: The key to treating bile acid diarrhea?

July 03, 2019

Estimates are that roughly 1 percent of people in Western countries may have bile acid diarrhea, including patients with Crohn's disease, ileal resection, diarrhea-predominant irritable bowel syndrome (IBS-D), and chronic functional diarrhea. Current management for bile acid diarrhea has demonstrated limited efficacy, with some therapies producing significant side effects. A recent study published in The FASEB Journal explored the efficacy of CFTR (cystic fibrosis transmembrane conductance regulator) inhibition to reduce excessive secretion in the colon due to bile acids.

Researchers studied cell culture models of human intestinal cells. Based on prior studies showing that chenodeoxycholic acid (CDCA) increases secretion in the colon and is linked to CFTR activation, researchers added CDCA to the cultures, which caused an increase in CFTR activity. They then added CFTR inhibitors to the cultures and used short-circuit current measurement to measure CFTR activity. Researchers found that CFTR inhibitors including investigational drug (R)-BPO-27 were able to fully block the increased CFTR activity.

"Bile acid diarrhea is a common problem for which therapeutic options are limited and often ineffective," said Alan S. Verkman, MD, PhD, a researcher within the Departments of Medicine and Physiology at the University of California, San Francisco. "Inhibition of chloride and fluid secretion in the intestine by a CFTR inhibitor offers a new therapeutic option to reduce diarrhea associated with excess bile acids."

Motivated by data implicating CFTR as a major determinant of bile acid secretion, the research team also tested the CFTR inhibitor in a rat model of bile acid diarrhea involving direct infusion of bile acids into the colon. Once again, (R)-BPO-27 was effective; this time, in reducing the increased stool water content.

"To see a physiologist as talented as Alan Verkman, and his colleagues, enter this field and offer such insights is a significant advance," said Thoru Pederson, PhD, Editor-in-Chief of The FASEB Journal.
This research was supported by grants from National Institutes of Health and the Cystic Fibrosis Foundation.

The FASEB Journal is published by the Federation of the American Societies for Experimental Biology (FASEB). The world's most cited biology journal according to the Institute for Scientific Information, it has been recognized by the Special Libraries Association as one of the top 100 most influential biomedical journals of the past century.

FASEB is composed of 29 societies with more than 130,000 members, making it the largest coalition of biomedical research associations in the United States. FASEB's mission is to advance health and well-being by promoting research and education in biological and biomedical sciences through collaborative advocacy and service to member societies and their members.

Federation of American Societies for Experimental Biology

Related Diarrhea Articles from Brightsurf:

How diarrhea pathogens switch into attack mode at body temperature
Many bacterial pathogens excrete toxins as soon as they have entered the host in order to suppress its immune response.

Scientists link La Niña climate cycle to increased diarrhea
A study in Botswana by Columbia University Mailman School of Public Health scientists finds that spikes in cases of life-threatening diarrhea in young children are associated with La NiƱa climate conditions.

Successful study of Swedish vaccine candidate against diarrhea
University of Gothenburg reports first successful results of the oral, inactivated vaccine candidate ETVAX against enterotoxigenic E. coli diarrhea in a placebo-controlled phase I/II study in infants and children from 6 months to 5 years of age in Bangladesh.

Rice bran may help curb malnutrition, diarrhea for infants
A new study led by Colorado State University found that adding rice bran for infants who were being weaned from their mother's milk resulted in them receiving more nutrients that enhanced growth and reduced diarrhea.

AGA releases guideline on the evaluation of chronic diarrhea
Diagnosing patients with chronic watery diarrhea can be difficult for health care providers, since several causes with specific therapies, such as inflammatory bowel disease (IBD), microscopic colitis and chronic infection, need to be ruled out.

Fighting child diarrhea
An automatic chlorine dispenser installed at shared community water points reduces rates of diarrhea in children.

Researchers determine bacteria structure responsible for traveler's diarrhea
For the first time researchers have deciphered the near-atomic structure of filaments, called 'pili', that extend from the surface of bacteria that cause traveler's diarrhea.

CFTR inhibition: The key to treating bile acid diarrhea?
Estimates are that roughly 1% of people in Western countries may have bile acid diarrhea, including patients with Crohn's disease, ileal resection, diarrhea-predominant irritable bowel syndrome (IBS-D), and chronic functional diarrhea.

Treatment for common cause of diarrhea more promising
Researchers at Washington University School of Medicine in St. Louis have figured out how to grow the intestinal parasite Cryptosporidium in the lab, an achievement that will speed efforts to treat or prevent diarrhea caused by the parasite.

Widely used public health surveys may underestimate global burden of childhood diarrhea
Public health surveys used in as many as 90 countries may be missing the number of recent diarrhea episodes among children by asking parents and caregivers to recall events two weeks versus one week out, suggests a study from researchers at Johns Hopkins Bloomberg School of Public Health.

Read More: Diarrhea News and Diarrhea Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to